Acumen Pharmaceuticals, Inc.

Acumen Pharmaceuticals, Inc.

生物技术研究

Greater Boston,MA 5,041 位关注者

Forging a new path towards a safe and effective treatment for Alzheimer’s disease.

关于我们

Acumen is forging a new path towards safe and effective treatments for Alzheimer’s disease and other neurodegenerative diseases through our focus on the biology of toxic soluble amyloid-beta oligomers. Our founders pioneered seminal discoveries and methods to understand the role of toxic amyloid-beta oligomers (Aβo) in synaptic dysfunction and neurodegeneration. These early insights have fostered decades of research on the biology of Aβo at Acumen and throughout the field. We are now on the on cusp of realizing the therapeutic potential of Aβo targeted drugs.

网站
https://www.acumenpharm.com
所属行业
生物技术研究
规模
51-200 人
总部
Greater Boston,MA
类型
上市公司
领域
Alzheimer's disease、Neurodegenerative disease、therapeutics、amyloid-beta oligomers、monoclonal anitbodies和immunotherapy

地点

Acumen Pharmaceuticals, Inc.员工

动态

相似主页

查看职位

融资